Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
Published Online: 2021-07-?
Journal: The Lancet•Publisher: Elsevier BV
Authors: Carol Wysham•Chrisanthi A Karanikas•Clare J Lee•Huzhang Mao•Juan P Frías•Julio Rosenstock•Laura Fernández Landó•Shizuka Kaneko•Vivian T Thieu•Xuewei Cui
